Chesapeake Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.34M Buy
2,026
+1,737
+601% +$2.05M 1.86% 25
2026
Q2
$347K Buy
289
+64
+28% +$65.4K 0.18% 149
2026
Q1
$207K Buy
225
+24
+12% +$24.3K 0.15% 156
2025
Q4
$216K Buy
+201
New +$192K 0.18% 153

Other funds holding LLY

Chesapeake Capital's LLY Position: Q3 2026 in Review

Chesapeake Capital increased its Eli Lilly (LLY) stake by 601% in Q3 2026, buying an estimated $2.05M and bringing the position to 2,026 shares worth $2.34M. The position accounts for 1.86% of the portfolio, ranked #25.

Chesapeake Capital first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Chesapeake Capital held 2,026 shares of Eli Lilly worth $2.34M as of Q3 2026.
  • Chesapeake Capital bought 1,737 Eli Lilly shares in Q3 2026, an estimated $2.05M.
  • Eli Lilly made up 1.86% of Chesapeake Capital's portfolio in Q3 2026, its #25 holding.
  • Chesapeake Capital first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Chesapeake Capital's 13F filing for Q3 2026, filed 9 Nov 2026.